STOCK TITAN

Insider at NTRA (NASDAQ: NTRA) files notice to sell company shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

An affiliate of the issuer, Michael Brophy, filed a Form 144 notice to sell 5,671 shares of common stock through Morgan Stanley Smith Barney on NASDAQ. These shares were acquired as restricted stock units on 09/28/2025, when payment was recorded as non-cash (N/A).

The filing notes that 138,014,465 common shares were outstanding and lists several sales during the prior three months, including transactions under a Rule 10b5-1 sales plan and direct sales, with individual trades as large as 36,573 and 23,948 shares of common stock.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many NTRA shares is Michael Brophy planning to sell under this Form 144?

Michael Brophy plans to sell 5,671 shares of common stock. The Form 144 shows these shares will be sold through Morgan Stanley Smith Barney on NASDAQ and that they were originally acquired as restricted stock units on September 28, 2025, in a non-cash transaction.

What type of NTRA securities are involved in Michael Brophy’s planned sale?

The planned sale involves common stock of the issuer. The Form 144 lists the class as “Common” and indicates that 5,671 common shares, originally received as restricted stock units, are expected to be sold on NASDAQ through Morgan Stanley Smith Barney’s Executive Financial Services platform.

How and when did Michael Brophy acquire the NTRA shares he plans to sell?

Brophy acquired the 5,671 shares on September 28, 2025 as restricted stock units. The table identifies the issuer as the source, shows the acquisition date and payment date as the same day, and describes the nature of payment as N/A, indicating a non-cash equity award.

What recent NTRA stock sales by Michael Brophy or his plans are disclosed?

The notice lists several common stock sales in the past three months. These include trades under a Rule 10b5-1 sales plan and direct sales, with individual transactions such as 36,573 shares and 23,948 shares of common sold in January 2026, generating multi-million-dollar gross proceeds.

What trading plan is referenced for Michael Brophy’s NTRA share sales?

Several transactions are tied to a Rule 10b5-1 sales plan. The filing identifies “10b5-1 Sales Plan for MICHAEL BROPHY” for multiple January 2026 sales of common stock, indicating pre-arranged trading instructions designed to follow Rule 10b5-1 under the Exchange Act.

How many NTRA shares were outstanding when this Form 144 was prepared?

The document reports 138,014,465 common shares outstanding. This figure appears in the securities information table alongside the planned 5,671-share sale, providing context on the issuer’s total common stock base at the time the Form 144 notice was prepared.
Natera Inc

NASDAQ:NTRA

NTRA Rankings

NTRA Latest News

NTRA Latest SEC Filings

NTRA Stock Data

31.75B
134.33M
3.2%
96.35%
2.7%
Diagnostics & Research
Services-medical Laboratories
Link
United States
AUSTIN